Fundz

ChronoScale Holdings Corporation Completes Sale of Ekso Bionics, Inc.

PUBLIC · CHRNOct 02, 2026

Acquiring Company

ChronoScale

Acquired Company

Ekso Bionics®

San RafaelSoftwareArtificial IntelligenceMachine LearningManufacturingBiotechnologyHealth CareMedical Device

Description

On September 30, 2026, ChronoScale Holdings Corporation completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc. This transaction marks a significant step for ChronoScale as it refocuses its business operations. The separation will enable both companies to pursue their strategic goals more effectively. Following this transaction, Jason C. Jones has been terminated from his position as COO of Ekso.

Company Information

Company

ChronoScale

About

ChronoScale is an accelerated compute platform purpose-built to support demanding artificial intelligence workloads. Focused on large-scale deployments, the platform delivers dedicated compute environments optimized for performance, consistency, and scalability. Its products serve various markets that require AI training, inference, and high-performance computing.

Fundz sees it the moment ChronoScale makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Alma
Senior decision-maker at this company
••••••••@••••••••

See Alma's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ChronoScale's next move

Learn about Strategic plan

Frequently asked

Who acquired Ekso Bionics®?

Ekso Bionics® was acquired by ChronoScale. The deal was reported on October 2, 2026. ChronoScale is an accelerated compute platform purpose-built to support demanding artificial intelligence workloads. ChronoScale is publicly traded (CHRN) and operates in Software.

When did ChronoScale acquire Ekso Bionics®?

ChronoScale's acquisition of Ekso Bionics® was reported on October 2, 2026. On September 30, 2026, ChronoScale Holdings Corporation completed the sale of its wholly owned subsidiary, Ekso Bionics, Inc. This transaction marks a significant step for ChronoScale as it refocuses its business operations. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Ekso Bionics® do?

® Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. It is publicly traded (CHRN), operating in Manufacturing, and is based in San Rafael.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.